Author:
Goodall E.,Oxtoby Christine,Richards Ray,Watkinson Gill,Brown David,Silversonte Trevor
Abstract
Twenty-nine overweight schizophrenic patients maintained on depot neuroleptic injections who wished to lose weight took part in a double-blind, placebo-controlled trial of 30 mg d-fenfluramine. All subjects received dietary advice. Sixteen patients completed the 12-week trial. Rate of weight loss was significantly greater in those taking d-fenfluramine. Side-effects were reported, but no deterioration in mental state was noted.
Publisher
Royal College of Psychiatrists
Subject
Psychiatry and Mental health
Reference21 articles.
1. Plasma fenfluramine levels, weight loss, and side effects.
2. Prevalence of Obesity in Patients Receiving Depot Antipsychotics
3. Effects of caloric restriction on behaviour and body weight during chlorpromazine therapy;Sletten;Diseases of the Nervous System,1967
4. The clinical pharmacology of appetite suppressant drugs;Silverstone;International Journal of Obesity,1984
Cited by
71 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献